The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells

  • Authors:
    • Javier De La Rosa
    • Alejandro Urdiciain
    • Idoya Zazpe
    • María V. Zelaya
    • Bárbara Meléndez
    • Juan A. Rey
    • Miguel A. Idoate
    • Javier S. Castresana
  • View Affiliations

  • Published online on: October 30, 2019     https://doi.org/10.3892/ijo.2019.4905
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Current treatment against glioblastoma consists of surgical resection followed by temozolomide, with or without combined radiotherapy. Glioblastoma frequently acquires resistance to chemotherapy and/or radiotherapy. Novel therapeutic approaches are thus required. The inhibition of enhancer of zeste homolog 2 (EZH2; a histone methylase) and histone deacetylases (HDACs) are possible epigenetic treatments. Temozolomide, 3‑deazaneplanocin A (DZ‑Nep; an EZH2 inhibitor) and panobinostat (an HDAC inhibitor) were tested in regular and temozolomide‑resistant glioblastoma cells to confirm whether the compounds could behave in a synergistic, additive or antagonistic manner. A total of six commercial cell lines, two temozolomide‑induced resistant cell lines and two primary cultures derived from glioblastoma samples were used. Cell lines were exposed to single treatments of the drugs in addition to all possible two‑ and three‑drug combinations. Colony formation assays, synergistic assays and reverse transcription‑quantitative PCR analysis of apoptosis‑associated genes were performed. The highest synergistic combination was DZ‑Nep + panobinostat. Triple treatment was also synergistic. Reduced clonogenicity and increased apoptosis were both induced. It was concluded that the therapeutic potential of the combination of these three drugs in glioblastoma was evident and should be further explored.

Related Articles

Journal Cover

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
De La Rosa, J., Urdiciain, A., Zazpe, I., Zelaya, M.V., Meléndez, B., Rey, J.A. ... Castresana, J.S. (1899). The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells. International Journal of Oncology, 0, 0-0. https://doi.org/10.3892/ijo.2019.4905
MLA
De La Rosa, J., Urdiciain, A., Zazpe, I., Zelaya, M. V., Meléndez, B., Rey, J. A., Idoate, M. A., Castresana, J. S."The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells". International Journal of Oncology 0.0 (1899): 0-0.
Chicago
De La Rosa, J., Urdiciain, A., Zazpe, I., Zelaya, M. V., Meléndez, B., Rey, J. A., Idoate, M. A., Castresana, J. S."The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells". International Journal of Oncology 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ijo.2019.4905